Copyright Reports & Markets. All rights reserved.

Global Diarrhea Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Diarrhea Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Rotavirus Vaccine
    • 1.3.3 Cholera Vaccine
    • 1.3.4 EV71 Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Diarrhea Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Newborn
    • 1.4.3 Adult
  • 1.5 Global Diarrhea Vaccine Market Size & Forecast
    • 1.5.1 Global Diarrhea Vaccine Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Diarrhea Vaccine Sales Quantity (2021-2032)
    • 1.5.3 Global Diarrhea Vaccine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 MSD
    • 2.1.1 MSD Details
    • 2.1.2 MSD Major Business
    • 2.1.3 MSD Diarrhea Vaccine Product and Services
    • 2.1.4 MSD Diarrhea Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 MSD Recent Developments/Updates
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Diarrhea Vaccine Product and Services
    • 2.2.4 Sanofi Diarrhea Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sanofi Recent Developments/Updates
  • 2.3 EuBiologics
    • 2.3.1 EuBiologics Details
    • 2.3.2 EuBiologics Major Business
    • 2.3.3 EuBiologics Diarrhea Vaccine Product and Services
    • 2.3.4 EuBiologics Diarrhea Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 EuBiologics Recent Developments/Updates
  • 2.4 Vabiotech
    • 2.4.1 Vabiotech Details
    • 2.4.2 Vabiotech Major Business
    • 2.4.3 Vabiotech Diarrhea Vaccine Product and Services
    • 2.4.4 Vabiotech Diarrhea Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Vabiotech Recent Developments/Updates
  • 2.5 PaxVax
    • 2.5.1 PaxVax Details
    • 2.5.2 PaxVax Major Business
    • 2.5.3 PaxVax Diarrhea Vaccine Product and Services
    • 2.5.4 PaxVax Diarrhea Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 PaxVax Recent Developments/Updates
  • 2.6 GlaxoSmithKline
    • 2.6.1 GlaxoSmithKline Details
    • 2.6.2 GlaxoSmithKline Major Business
    • 2.6.3 GlaxoSmithKline Diarrhea Vaccine Product and Services
    • 2.6.4 GlaxoSmithKline Diarrhea Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GlaxoSmithKline Recent Developments/Updates
  • 2.7 Serum Institute of India
    • 2.7.1 Serum Institute of India Details
    • 2.7.2 Serum Institute of India Major Business
    • 2.7.3 Serum Institute of India Diarrhea Vaccine Product and Services
    • 2.7.4 Serum Institute of India Diarrhea Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Serum Institute of India Recent Developments/Updates
  • 2.8 Bharat Biotech
    • 2.8.1 Bharat Biotech Details
    • 2.8.2 Bharat Biotech Major Business
    • 2.8.3 Bharat Biotech Diarrhea Vaccine Product and Services
    • 2.8.4 Bharat Biotech Diarrhea Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Bharat Biotech Recent Developments/Updates
  • 2.9 Chinese Academy of Medical Sciences
    • 2.9.1 Chinese Academy of Medical Sciences Details
    • 2.9.2 Chinese Academy of Medical Sciences Major Business
    • 2.9.3 Chinese Academy of Medical Sciences Diarrhea Vaccine Product and Services
    • 2.9.4 Chinese Academy of Medical Sciences Diarrhea Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Chinese Academy of Medical Sciences Recent Developments/Updates
  • 2.10 Sinovac Biotech Ltd
    • 2.10.1 Sinovac Biotech Ltd Details
    • 2.10.2 Sinovac Biotech Ltd Major Business
    • 2.10.3 Sinovac Biotech Ltd Diarrhea Vaccine Product and Services
    • 2.10.4 Sinovac Biotech Ltd Diarrhea Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Sinovac Biotech Ltd Recent Developments/Updates
  • 2.11 China National Biotec Corporation
    • 2.11.1 China National Biotec Corporation Details
    • 2.11.2 China National Biotec Corporation Major Business
    • 2.11.3 China National Biotec Corporation Diarrhea Vaccine Product and Services
    • 2.11.4 China National Biotec Corporation Diarrhea Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 China National Biotec Corporation Recent Developments/Updates
  • 2.12 Shanghai United Cell Biotechnology
    • 2.12.1 Shanghai United Cell Biotechnology Details
    • 2.12.2 Shanghai United Cell Biotechnology Major Business
    • 2.12.3 Shanghai United Cell Biotechnology Diarrhea Vaccine Product and Services
    • 2.12.4 Shanghai United Cell Biotechnology Diarrhea Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Shanghai United Cell Biotechnology Recent Developments/Updates

3 Competitive Environment: Diarrhea Vaccine by Manufacturer

  • 3.1 Global Diarrhea Vaccine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Diarrhea Vaccine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Diarrhea Vaccine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Diarrhea Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Diarrhea Vaccine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Diarrhea Vaccine Manufacturer Market Share in 2025
  • 3.5 Diarrhea Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Diarrhea Vaccine Market: Region Footprint
    • 3.5.2 Diarrhea Vaccine Market: Company Product Type Footprint
    • 3.5.3 Diarrhea Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Diarrhea Vaccine Market Size by Region
    • 4.1.1 Global Diarrhea Vaccine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Diarrhea Vaccine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Diarrhea Vaccine Average Price by Region (2021-2032)
  • 4.2 North America Diarrhea Vaccine Consumption Value (2021-2032)
  • 4.3 Europe Diarrhea Vaccine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Diarrhea Vaccine Consumption Value (2021-2032)
  • 4.5 South America Diarrhea Vaccine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Diarrhea Vaccine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Diarrhea Vaccine Sales Quantity by Type (2021-2032)
  • 5.2 Global Diarrhea Vaccine Consumption Value by Type (2021-2032)
  • 5.3 Global Diarrhea Vaccine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Diarrhea Vaccine Sales Quantity by Application (2021-2032)
  • 6.2 Global Diarrhea Vaccine Consumption Value by Application (2021-2032)
  • 6.3 Global Diarrhea Vaccine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Diarrhea Vaccine Sales Quantity by Type (2021-2032)
  • 7.2 North America Diarrhea Vaccine Sales Quantity by Application (2021-2032)
  • 7.3 North America Diarrhea Vaccine Market Size by Country
    • 7.3.1 North America Diarrhea Vaccine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Diarrhea Vaccine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Diarrhea Vaccine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Diarrhea Vaccine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Diarrhea Vaccine Market Size by Country
    • 8.3.1 Europe Diarrhea Vaccine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Diarrhea Vaccine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Diarrhea Vaccine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Diarrhea Vaccine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Diarrhea Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Diarrhea Vaccine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Diarrhea Vaccine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Diarrhea Vaccine Sales Quantity by Type (2021-2032)
  • 10.2 South America Diarrhea Vaccine Sales Quantity by Application (2021-2032)
  • 10.3 South America Diarrhea Vaccine Market Size by Country
    • 10.3.1 South America Diarrhea Vaccine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Diarrhea Vaccine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Diarrhea Vaccine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Diarrhea Vaccine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Diarrhea Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Diarrhea Vaccine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Diarrhea Vaccine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Diarrhea Vaccine Market Drivers
  • 12.2 Diarrhea Vaccine Market Restraints
  • 12.3 Diarrhea Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Diarrhea Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Diarrhea Vaccine
  • 13.3 Diarrhea Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Diarrhea Vaccine Typical Distributors
  • 14.3 Diarrhea Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Diarrhea Vaccine market size was valued at US$ 1210 million in 2025 and is forecast to a readjusted size of US$ 1430 million by 2032 with a CAGR of 2.4% during review period.
    Diarrhea vaccines generally refer to vaccines used to prevent infectious diarrhea caused by specific pathogens (such as rotavirus, norovirus, etc.). There are many types of diarrhea vaccines, mainly including EV71 vaccines, rotavirus vaccines, and cholera vaccines. The global market size is currently over $1.2 billion, with the Chinese market exceeding $400 million.
    This report is a detailed and comprehensive analysis for global Diarrhea Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Diarrhea Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
    Global Diarrhea Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
    Global Diarrhea Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
    Global Diarrhea Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Diarrhea Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Diarrhea Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MSD, Sanofi, EuBiologics, Vabiotech, PaxVax, GlaxoSmithKline, Serum Institute of India, Bharat Biotech, Chinese Academy of Medical Sciences, Sinovac Biotech Ltd, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Diarrhea Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Rotavirus Vaccine
    Cholera Vaccine
    EV71 Vaccine
    Market segment by Application
    Newborn
    Adult
    Major players covered
    MSD
    Sanofi
    EuBiologics
    Vabiotech
    PaxVax
    GlaxoSmithKline
    Serum Institute of India
    Bharat Biotech
    Chinese Academy of Medical Sciences
    Sinovac Biotech Ltd
    China National Biotec Corporation
    Shanghai United Cell Biotechnology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Diarrhea Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Diarrhea Vaccine, with price, sales quantity, revenue, and global market share of Diarrhea Vaccine from 2021 to 2026.
    Chapter 3, the Diarrhea Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Diarrhea Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Diarrhea Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Diarrhea Vaccine.
    Chapter 14 and 15, to describe Diarrhea Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now